Report cover image

Global Biologics Contract Development Market Size, Trends & Growth Opportunity, By Source (Microbial, Mammalian, and Others), By Product Service (Cell Line Development, Process Development, Product, and Others), By Disease Indication, By Region and Forec

Publisher QualiKet Research
Published Feb 11, 2023
Length 150 Pages
SKU # QUA17762570

Description

Global Biologics Contract Development Market Size, Trends & Growth Opportunity, By Source (Microbial, Mammalian, and Others), By Product Service (Cell Line Development, Process Development, Product, and Others), By Disease Indication, By Region and Forecast till 2027.

Global Biologics Contract Development Market

The global Biologics Contract Development market was valued at US$ 9.93 billion in 2021 and it is expected to reach at US$ 18.15 billion in 2027 at a CAGR of 10.8 % during forecast period 2022-2027.

Biologics contract development organizations provide complete services from cell line development to long term commercial supply of biological products. They offer various services including development of cell lines, analytical and bio-analytical methods, upstream and downstream processes, and formulations and quality assessment. This is type of outsourcing where manufacturer enters into formal agreement with another manufacturing organization for its parts, components, and products.

Market Drivers

Rise in adoption of advanced technologies for biological production is the key driving factor which is expected to boost the global biologics contract development market growth. Furthermore, increase in outsourcing of research and development activities by pharma and bio-pharma companies and favourable regulatory environment for clinical trials in developing nations will positively contribute the market growth. Moreover, increase in number of mergers and collaborations will propel the market growth. For instance, in March 2019, Thermo Fischer Scientific had announced that it will acquire Brammer Bio, which is leading viral vector contract developer for cell and gene therapies. The main aim of this acquisition is strengthening its product portfolio in the area of gene therapy. In addition to that, increase in prevalence of various diseases such as cancer, neurological disorders, and cardiovascular diseases will fuel the market growth. For instance, as per the World Health Organization (WHO) approximately 8.2 million people die each year due to cancer worldwide. Many biologics contract organizations are now shifting to Single Use Bioreactors that offer lower up front capital costs, improved throughputs, and greater manufacturing flexibility will drive the biologicas contract development market growth.

Market Restraints

However, change in trade policies between countries is the major challenging factor which is expected to hinder the global biologics contract development market growth during this analysis period.

Covid-19 Impact

Due to outbreak of covid -19 as public emergency and pandemic declared there is increase in demand for medical supplies,the devices like atomizers,life-support machines,oxygen generators,PPE kit which significantly impact the market growth.

Recent Development

In 2021, Almac Group launch of biologics contract of testing and development solutions which helps in development and testing of new biologics products.In 2020, Lake Pharma In, launch integrated chemistry and biologics services for streamlined antibody- drug conjugates development solutions for pharmaceutical and biotechnology sectors.

Market Segmentation

Global Biologics Contract Development Market is segmented into source such as Microbial, Mammalian, and Others, by product service such as Cell Line Development, Process Development (Upstream, and Downstream), product ( MABs, Recombinant Proteins, and Others), and Others. Further, market is segmented into disease indication such as Oncology, Immunological Disorder, Cardiovascular Disorder, Haematological Disorder, and Others.

Also, Global Biologics Contract Development Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as WuXi Biologics, Fujifilm Diosynth Biotechnologies, Abzena Ltd., AGC Biologics, KBI Biopharma, SE Thermo Fisher (Patheon), LakePharma, Genscript Biotech Corporation, Bionova Scientific, and Boehringer Ingelheim BioXcellence etc.

Market Taxonomy

By Source
  • Microbial
  • Mammalian
  • Others
By Product Service
  • Cell Line Development
  • Process Development
  • Upstream
  • Downstream
  • Product
  • MABs
  • Recombinant Proteins
  • Others
  • Others
By Disease Indication
  • Oncology
  • Immunological Disorder
  • Cardiovascular Disorder
  • Hematological Disorder
  • Others
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Questions Addressed by the Report
  • What are the Key Opportunities in Global Biologics Contract Development Market?
  • What will be the growth rate from 2022 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?

Table of Contents

150 Pages
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Biologics Contract Development Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Biologics Contract Development Market, By Source
5.1 Y-o-Y Growth Comparison, By Source
5.2 Global Biologics Contract Development Market Share Analysis, By Source
5.3 Global Biologics Contract Development Market Size and Forecast, By Source
5.3.1 Microbial
5.3.2. Mammalian
5.3.3 Others
6 Global Biologics Contract Development Market, By Product Service
6.1 Y-o-Y Growth Comparison, By Product Service
6.2 Global Biologics Contract Development Market Share Analysis, By Product Service
6.3 Global Biologics Contract Development Market Size and Forecast, By Product Service
6.3.1Cell Line Development
6.3.2 Process Development
6.2.2.1 Upstream
6.2.2.2 Downstream
6.3.3. Product
6.3.3.1 MABs
6.3.3.2. Recombinant Process
6.3.3.3. Others
6.3.3.3. Others
7 Global Biologics Contract Development Market, By Diseases Indication
7.1 Y-o-Y Growth Comparison, By Diseases Indication
7.2 Global Biologics Contract Development Market Share Analysis, By Diseases Indication
7.3 Global Biologics Contract Development Market Size and Forecast, By Diseases Indication
7.3. 1 Oncology
7.3.2. Immunological Disorder
7.3.3. Cardiovascular Disorder
7.3.4. Hematological Disorder
7.3.5. Others
8 Global Biologics Contract Development Market, By Region
8.1 Global Biologics Contract Development Market Share Analysis, By Region
8.2 Global Biologics Contract Development Market Share Analysis, By Region
8.3 Global Biologics Contract Development Market Size and Forecast, By Region
9 North America Biologics Contract Development Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Biologics Contract Development Market Share Analysis, By Source
9.3 North America Biologics Contract Development Market Size and Forecast, By Product Service
9.4 North America Biologics Contract Development Market Size and Forecast, By Diseases Indication
9.5 North America Biologics Contract Development Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 EuropeBiologics Contract Development Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Biologics Contract Development Market Share Analysis, By Source
10.3 Europe Biologics Contract Development Market Size and Forecast, By Product Service
10.4 Europe Biologics Contract Development Market Size and Forecast, By Diseases Indication
10.5 Europe Biologics Contract Development Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Biologics Contract Development Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Biologics Contract Development Market Share Analysis, By Source
11.3 Asia Pacific Biologics Contract Development Market Size and Forecast, By Product Service
11.4 Asia Pacific Biologics Contract Development Market Size and Forecast, By Diseases Indication
11.5 Asia Pacific Biologics Contract Development Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Biologics Contract Development Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Biologics Contract Development Market Share Analysis, By Source
12.3 Latin America Biologics Contract Development Market Size and Forecast, By Product Service
12.4 Latin America Biologics Contract Development Market Size and Forecast, By Diseases Indication
12.5 Latin America Biologics Contract Development Market Size and Forecast, Country
13 Middle East Biologics Contract Development Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Biologics Contract Development Market Share Analysis, By Source
13.3 Middle East Biologics Contract Development Market Size and Forecast, By Product Service
13.4 Middle East Biologics Contract Development Market Size and Forecast, By Diseases Indication
13.5 Middle East Biologics Contract Development Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 WuXi Biologics
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Fujifilm Diosynth Biotechnologies
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Abzena Ltd
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 AGC Biologics
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 KBI Biopharma
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 SE Thermo Fisher (Patheon)
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 LakePharma
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Genscript Biotech Corporation
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Bionova Scientific
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Boehringer Ingelheim BioXcellence
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us